Objective: The activation of RET proto-oncogene, through different types of chromosomal translocation and inversion, is unique to papillary thyroid carcinomas (PTC) and its frequency is variable in different populations. The aim of this study was to investigate the frequency and types of PTC genetic rearrangements in papillary carcinoma in a population of Hong Kong Chinese. Methods: The presence of RET/PTC1, RET/PTC2 and RET/PTC3 activation was analyzed by RT-PCR in twenty PTC from adult patients (age range 24 -63 years), one PTC from a 12-year-old boy and anaplastic carcinomas in two adult patients. Results: RET/PTC3 was the only activation of RET proto-oncogene identified in the samples. Seventeen PTC from adult patients (85%t) were positive for RET/PTC3. RET/PTC3 was also identified in PTC from the child and one of the two patients with anaplastic thyroid carcinoma. Conclusions: The prevalence of RET/PTC activation in PTC is high and RET/PTC3 is the only type of activation identified in Hong Kong Chinese and is an important genetic event underlying the development of PTC in the population.
Introduction
Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy (1) . The tumor is associated with somatic mutations of RET proto-oncogene, which is activated by gene rearrangements (2) . The rearranged proto-oncogene, PTC oncogene (RET/PTC) is the product of the fusion of the tyrosine-kinase domain of the proto-RET to other genes. The three most common variants are RET/PTC1, RET/PTC2 and RET/PTC3 (2) . In RET/PTC1 and RET/PTC3 the tyrosine-kinase domain fuses with the genes H4 and ELE1 respectively. RET/PTC2 arises from chromosome 10/17 translocation. There are also a number of RET/PTC activation variants, RET/PTC4, RET/PTC5, RET/PTC6, RET/PTC7, RET/PTC8, etc. (3) .
The frequency of RET/PTC activation varies widely between reported series from different ethnic groups (4) . In Hong Kong, despite the high incidence of thyroid cancers, there are no data on the characteristics of RET activation in thyroid cancers. In the present report, we examine the incidence and type of RET/PTC activation in thyroid cancers obtained from a population of Chinese from Hong Kong.
Subjects and methods

Subjects
Tissue samples were obtained prospectively from Chinese patients with thyroidectomy for confirmed thyroid cancer performed between 1996 and 2000 at Queen Mary Hospital, Hong Kong. Twenty-three patients with primary thyroid cancer were selected for the study ( Table 1) . None of the patients had a previous history of radiation exposure. The thyroid cancers comprised twenty-one PTC and two anaplastic carcinomas of the thyroid gland. The size and location of the thyroid cancer were examined at the time of surgery. Representative blocks were snap frozen in liquid nitrogen immediately after removal and stored in a 2 708 refrigerator. Other sections of the thyroid gland were sectioned serially and embedded for histological examination. The histology was determined according to standard criteria (4) . Patients with papillary microcarcinoma were excluded from the study. The thyroid cancers that were kept frozen were confirmed to be free of normal tissue on histological examination. The staging was done according to the classification of the American Joint Committee on Cancer (5) . The clinical data and follow-up information of these patients were also retrieved and analyzed.
Methods
The RET activation in the thyroid cancers was studied by reverse transcriptase-polymerase chain reaction (RT-PCR). Total RNA was isolated from the selected thyroid cancers using a Trizol isolation kit according to the instructions from the manufacturer (GIBCO-BRL, Grand Island, NY, USA). The resultant pellet was then resuspended in water treated with diethylpyrocarbonate. The total RNA was studied by gel electrophoresis and quantified by spectrophotometry. The procedure for RT-PCR was modified as described in a previous study (6) . Total RNA (1 -5 mg) was subjected to first strand cDNA synthesis using a system of oligo (dT) primers and Superscript II transcriptase (GIBCO-BRL) in a final volume of 20 ml. After incubation at 42 8C for 1 h, the reaction mixture was treated with RNase H before proceeding to PCR analysis.
PCR amplification was obtained in a final reaction volume of 100 ml. The reaction mixture was comprised of 10 ml PCR buffer (10 £ ), 200 mM Tris -HCl (pH 8.4), 500 mM KCl, 3 ml 50 mM MgCl 2 , 2 ml each of the sense and antisense primers (10 mM), 1 ml Taq DNA polymerase (1 -5 U/ml), 2 ml cDNA and 80 ml water. An expression study was performed using specific oligonucleotide primers for PTC1, PTC2 and PTC3 as employed by Viglietto et al. (7) . The sequence of the forward primers used were: RET/PTC1: 5 0 -ATTG-TCATCTCGCCGTTC-3 0 ; RET/PTC2: 5 0 -TATCGCAGGAG-AGACTGTGAT-3 0 ; RET/PTC3: 5 0 -AAGCAAACCTGCCA-GTGG-3 0 . The sequence of the reverse primer was 5 0 -TGCTTCAGGACGTTGAAC-3 0 . Human b-actin was used as a positive control for PCR reaction with a sequence of 5 0 -GGCTACAGCTTCACCACCA-3 0 as forward primer and 5 0 -ACGGATGTCCACGTCACAC-3 0 as reverse primer. The RNA was tested to be free of DNA contamination by RT-PCR without the addition of reverse transcriptase. The PCR conditions were 40 cycles of denaturing at 94 8C for 1 min, annealing at 60 8C for 1 min and elongating at 72 8C for 2 min. Lastly, the amplified mixture (10 ml) was finally separated on 2% agarose gel electrophoresis and the amplified DNA bands were detected using ethidium bromide staining.
Results
Twenty-three patients with thyroid cancer were selected for the study ( Table 1) . None of the patients had a previous history of radiation exposure. The thyroid cancers comprised 21 PTC and two anaplastic carcinomas of the thyroid gland.
Apart from one PTC obtained from a 12-year-old boy, the other papillary carcinomas were seen in adults (14 women, 6 men) with a mean age of 51 years (range from 24 to 83 years). The average tumor size was Among the twenty PTC from adult patients, seventeen were positive for RET/PTC3 activation ( Fig. 1) . They were negative for RET/PTC1 and RET/PTC2 activation. Negativity for RET/PTC activation occurred in two men and one woman. The presence of the RET/PTC activation showed no relation to the age of the patients, size of the thyroid tumors, location of the thyroid tumors, lymph node status or extent of the tumor. The papillary thyroid carcinoma from the child also showed positive RET/PTC3 activation.
One of the two patients with anaplastic carcinoma was positive for RET/PTC3 activation. On histological examination, the anaplastic carcinoma positive for RET/PTC3 activation showed a minor component of papillary carcinoma.
Discussion
RT-PCR is a widely accepted method for the detection of RET/PTC activation. The method is sensitive and allows the identification of different types of activation in PCA ( Table 2) .
Radiation-induced PTC is associated with a high incidence of RET/PTC activation. The average prevalence rate in PTC of patients affected by the Chernobyl nuclear plant fall-out in 1986 was 63% (range 51 -87%) (8 -11) . High prevalence rate (84%) of RET/PTC was also detected in the patients with PTC who had a history of neck irradiation (11, 12) .
Overall, areas exposed to radiation had a higher prevalence of RET/PTC activation in PTC compared with that in other areas. Patients with PTC from European countries (not directly affected by the Chernobyl accident) had an average of 19% (range 8-50%) prevalence of RET/PTC activation (11) (12) (13) (14) (15) (16) (17) . On the other hand, series from North America reported that approximately half (range 45 -77%) of the PTC had RET/PTC activation (8, 18 -20) . Chua et al. (21) also reported a high prevalence (77%) of activation in PTC from Australia and New Caledonia. In these areas, ozone depletion has affected ambient radiation levels. This may explain the high incidence of RET/PTC activation.
The prevalence of RET/PTC activation in PTC has regional variations in Asia. In general, the prevalence reported is low in Korea (0 -13%) and Japan (25 -36%) (16, 22 -24) . On the other hand, the prevalence of RET/PTC activation seems to be high in Chinese populations. Lee et al. (25) reported a 55% (6 out of 11) prevalence in Chinese patients in Taiwan. In the current series, we found that 85% (17 out of 20) of PTC in our Hong Kong Chinese adult patients had RET/PTC activation. The prevalence is as high as those reported in thyroid tumors from Australia and areas exposed to the Chernobyl accident. It is possible then, that over and above environmental influences and the difference in means of detection of RET/PTC activation, genetic factors may account for the different prevalence of RET/PTC in PTC.
Among the three types of RET/PTC activation, RET/PTC3 is the commonest type of activation noted in childhood thyroid cancers from areas exposed to the Chernobyl accident (8 -11) . In other populations, RET/PTC1 is the activation most often noted in thyroid PTC. Tumors with more than one type of RET/PTC activation are sometimes found in PTC reported from North America and Australia (8, 18 -20) . In nearly all series, RET/PTC2 activation was uncommon in PTC. However, Lee et al. (25) in Taiwan reported that the most common RET/PTC activation in thyroid PTC was RET/PTC2.
In our population, RET/PTC3 was the only type of RET/PTC activation identified in PTC. This finding is unusual in sporadic non-radiation-induced PTC. Nevertheless, Kitamura et al. (16) in Japan reported a similar finding of a high incidence of RET/PTC3 in non-radiation-related thyroid PTC. They found that 60% of the thyroid cancers had RET/PTC3 activation. The type of RET/PTC activation from PTC in Asian cities may be different from the Western populations and genetic differences between various populations may be responsible for such differences.
The presence of RET/PTC activation may have a prognostic role in PTC. In the present series, the prevalence of the RET/PTC activation was high and thus no significant correlation of the RET activation with the clinicopathological factors could be demonstrated.
The majority of anaplastic carcinomas arise from pre-existing well-differentiated thyroid carcinoma, such as PTC, rather than de novo. In fact, papillary carcinomas could be detected as a minor component in some cases of papillary thyroid carcinomas. La Perle et al. (26) demonstrated in mice that the lack of functional p53 in RET/PTC1-induced thyroid tumors promoted anaplasia and invasiveness of thyroid carcinoma. In fact, we had previously demonstrated that the p53 mutation was only present in anaplastic carcinomas but not in PTC or poorly differentiated thyroid carcinomas (27) . In the present series, one anaplastic carcinoma was also positive for RET/PTC activation. In this case, the presence of a minor component of papillary carcinoma was also noted on histological examination. Thus, the RET/PTC activation in the RT, radiation exposure. In multiple series on the same group of patients, the one that is largest or that with information on different types of RET/PTC is listed.
anaplastic carcinoma may be attributed to the presence of the PTC in the vicinity of the anaplastic carcinoma. The other anaplastic carcinoma without this welldifferentiated thyroid carcinoma component did not reveal any RET/PTC activation. The findings are in agreement with the notion that RET/PTC is an early event but p53 mutation is a late event in the carcinogenesis of thyroid cancers. In summary, the prevalence of RET/PTC activation is high and the type of activation is unique in PTC in Chinese populations. As suggested by the results of this study, RET activation may be an important genetic event underlying the development of papillary thyroid carcinomas in Hong Kong Chinese.
